Paris, France · Founded 2008 · Privately Held (backing)
Developer of pharmaceuticals and diagnostic tests designed for developing off-the-shelf, transformational cancer treatments targeting all tumor types. Enterome is based in Paris, France and was founded in 2008. Its last reported valuation was $217 million in Jul 2022. It has raised $292 million.
Last reported valuation
$217.0M
Oct 2026
Priced at
—
Total raised
$292.3M
Last round
—
Team — not yet on record
No current team members for Enterome are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Enterome with a free account
·The complete investor list: 18 names
·Watch Enterome: the Monday email on marks, rounds and moves
